Prior studies19–22 including ours23,24 have suggested that expression levels of estrogen receptor (ER), progesterone receptor (PR), IGF-1 receptor (IGF-1R), and Ki67 in cancer-free breast tissue may be associated with subsequent breast cancer risk. This evidence concerns the gene MKI67 and cancer.